CJC-1295 with DAC: A GHRH peptide modified with a drug affinity complex, which can briefly bind to serum albumin, thus significantly prolonging its half-life in vivo. Common CAS number: 863288-34-0.https://www.giantrawsource.com/peptides/peptides-powder-cjc1295-with-dac.html
CJC-1295 without DAC: A short-acting GHRH peptide that does not bind to albumin, has a shorter half-life, and produces a more natural pulsatile release of growth hormone. Common CAS number: 446036-97-1.
Mechanism of Action Comparison
Similarities: Both stimulate growth hormone (GH) release by activating pituitary GHRH receptors and can indirectly increase IGF-1.
Differences: DAC modification allows the peptide molecule to remain in the bloodstream longer, resulting in a longer, more stable GH stimulation; the unmodified version tends to stimulate short-duration, pulsatile GH release, which is closer to the physiological rhythm.






